AI-Driven Drug Discovery (BioAI Pharma) and Its Impact on Healthcare Equity (2025 Assessment) AI-driven drug discovery is reshaping pharmaceutical development, offering dual implications for healthcare equity: it can accelerate equitable global health resource allocation but may also exacerbate disp … AI-Driven Drug Discovery (BioAI Pharma) and Its Impact on Healthcare Equity (2025 Assessment)Read more
bioai
BioAI Genome: Ushering in the Programmable Era of Genomics and a Paradigm Shift
BioAI Genome: Ushering in the Programmable Era of Genomics and a Paradigm Shift The “programmable era” of genomics is defined by the deep integration of artificial intelligence (AI) and gene-editing technologies, enabling precise programming and functional redesign of biological systems … BioAI Genome: Ushering in the Programmable Era of Genomics and a Paradigm ShiftRead more